Immatics (IMTX) EBITDA Margin Growth (1y) (2020 - 2025)
Immatics (IMTX) EBITDA Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | -19,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,833.00 |
| Sep 30, 2025 | -95,292.00 |
| Jun 30, 2025 | -93,184.00 |
| Mar 31, 2025 | -28,367.00 |
| Dec 31, 2024 | 19,514.00 |
| Sep 30, 2024 | 44,402.00 |
| Jun 30, 2024 | 2,165.00 |
| Mar 31, 2024 | 22,948.00 |
| Dec 31, 2023 | -7,416.00 |
| Sep 30, 2023 | -33,544.00 |
| Jun 30, 2023 | -4,302.00 |
| Mar 31, 2023 | -31,956.00 |
| Dec 31, 2022 | 6,434.00 |
| Sep 30, 2022 | 28,673.00 |
| Jun 30, 2022 | 45,128.00 |
| Mar 31, 2022 | 40,685.00 |
| Dec 31, 2021 | 4,372.00 |
| Sep 30, 2021 | 174,351.00 |
| Jun 30, 2021 | -18,284.00 |
| Mar 31, 2021 | -20,241.00 |